Lexaria Bioscience Corp (LEXX) — Strategic Asset Allocation Index
Lexaria Bioscience Corp (LEXX) has a Strategic Asset Allocation Index of 11.3% as of May 2023. Strategic assets (PP&E of $455.02K plus long-term investments of $-) total $455.02K, measured against net assets of $4.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Lexaria Bioscience Corp Strategic Asset Allocation Index (2017–2022)
This chart shows how Lexaria Bioscience Corp's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of May 2023, the index stands at 11.3%, representing strategic assets of $455.02K against net assets of $4.04 Million USD. Explore LEXX cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Lexaria Bioscience Corp (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Lexaria Bioscience Corp from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see LEXX market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.8% | $367.95K | $367.95K | $- | $7.63 Million | ▲ +1.3 pp |
| 2021 | 3.5% | $459.25K | $459.25K | $- | $13.06 Million | ▼ -21.1 pp |
| 2020 | 24.6% | $610.28K | $610.28K | $- | $2.48 Million | ▲ +0.8 pp |
| 2019 | 23.7% | $591.26K | $591.26K | $- | $2.49 Million | ▲ +23.7 pp |
| 2018 | 0.1% | $1.24K | $1.24K | $- | $2.39 Million | ▼ 0.0 pp |
| 2017 | 0.1% | $1.86K | $1.86K | $- | $2.77 Million | — |